NASDAQ Market System Status - Today's
System Status Messages
| Time | Market | Status |
|---|---|---|
| 16:21:40 ET | NASDAQ NTX Post - Trade NASDAQ Options PHLX | Systems are operating normally |
Regulatory Messages
| Time | Market | Status |
|---|---|---|
| 16:21:40 ET | NASDAQ NTX NASDAQ Options | There are no messages available |
IPO Messages
| Time | Market | Status |
|---|---|---|
| 12:53:33 ET | NASDAQ | IPO Notice Update: The initial public offering of company Generate Biomedicines, Inc. (GENB) has officially opened for trading. Time: 12:50:35 For additional information please contact Nasdaq Trading Services at (212) 231-5180. |
| 12:49:56 ET | NASDAQ | IPO Notice Update: The initial public offering of security, Generate Biomedicines, Inc. (GENB) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs. |
| 12:39:10 ET | NASDAQ | IPO Notice Update: The initial public offering of security, Generate Biomedicines, Inc. (GENB) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs. |
| 12:29:17 ET | NASDAQ | IPO Notice Update: The initial public offering of security, Generate Biomedicines, Inc. (GENB) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs. |
| 12:19:03 ET | NASDAQ | IPO Notice Update: The initial public offering of security, Generate Biomedicines, Inc. (GENB) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs. |
| 12:09:28 ET | NASDAQ | IPO Notice Update: The initial public offering of security, Generate Biomedicines, Inc. (GENB) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs. |
| 11:59:57 ET | NASDAQ | IPO Notice Update: The initial public offering of security, Generate Biomedicines, Inc. (GENB) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs. |
| 11:49:36 ET | NASDAQ | IPO Notice Update: The initial public offering of security, Generate Biomedicines, Inc. (GENB) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs. |
| 11:41:11 ET | NASDAQ | IPO Notice Update: The initial public offering of security, Generate Biomedicines, Inc. (GENB) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs. |
| 11:32:15 ET | NASDAQ | IPO Notice Update: The initial public offering of security, Generate Biomedicines, Inc. (GENB) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs. |
| 11:19:16 ET | NASDAQ | IPO Notice Update: The initial public offering of security, Generate Biomedicines, Inc. (GENB) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs. |
| 11:09:38 ET | NASDAQ | IPO Notice Update: The initial public offering of security, Generate Biomedicines, Inc. (GENB) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs. |
| 10:59:46 ET | NASDAQ | IPO Notice Update: The initial public offering of security, Generate Biomedicines, Inc. (GENB) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs. |
| 10:49:18 ET | NASDAQ | IPO Notice Update: The initial public offering of security, Generate Biomedicines, Inc. (GENB) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs. |
| 10:39:09 ET | NASDAQ | IPO Notice Update: The initial public offering of security, Generate Biomedicines, Inc. (GENB) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs. |
| 10:30:59 ET | NASDAQ | IPO Notice Update: The initial public offering of Illumination Acquisition Corp I (ILLUU) has officially opened for trading. Time: 10:29:39 For additional information please contact Nasdaq Trading Services at (212) 231-5180. |
| 10:29:18 ET | NASDAQ | IPO Notice Update: The initial public offering of security, Generate Biomedicines, Inc. (GENB) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs. |
| 09:04:06 ET | NASDAQ | IPO Notice: The initial public offering of Illumination Acquisition Corp I (ILLUU) will be released on Nasdaq today for quotation at 10:10 a.m. ET and will be eligible for trading at approximately 10:20 a.m. ET. Orders are now being accepted. Please call 877-308-0523 if you have any questions. Reminder: Trading is prohibited during quote-only period of IPOs. |
| 08:04:57 ET | NASDAQ | IPO Notice: The initial public offering of Generate Biomedicines, Inc. (GENB) will be released on Nasdaq today for quotation at 10:10 a.m. ET and will be eligible for trading at approximately 10:20 a.m. ET. Orders are now being accepted. Please call 877-308-0523 if you have any questions. Reminder: Trading is prohibited during quote-only period of IPOs. |
Self-Help Messages
| Time | Market | Status |
|---|---|---|
| 16:21:40 ET | NASDAQ NTX PSX NASDAQ Options | There are no messages available |

RSS Feeds
Product Login